OSTEOPOROSIS INTERNATIONAL

OSTEOPOROSIS INTERNATIONAL(英文缩写 OSTEOPOROSIS INT),ISSN 0937-941X,eISSN 1433-2965 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

OSTEOPOROSIS INTERNATIONAL 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

1. NICE continues to muddy the waters of osteoporosis.
   J A Kanis, J E Compston
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18528723
   查看详情 DOI
2. Management of patients with Paget's disease: a consensus document of the Belgian Bone Club.
   J-P Devogelaer, P Bergmann, J-J Body, Y Boutsen, S Goemaere, J-M Kaufman
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18504638

   Paget's disease of bone (PDB) is a potentially crippling condition. Pain, fracture, spinal stenosis, nerve entrapment, vascular steal syndrome, secondary osteoarthritis, bone deformity, dental problem…

   查看详情 DOI
3. Routine versus targeted vertebral fracture assessment for the detection of vertebral fractures.
   E T Middleton, S A Steel
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18338099

   Fracture risk is underestimated in women with unknown vertebral fractures. Using VFA, we compared two screening methods: targeted (6,388 women) and routine (2,176 women). Routine screening detected fr…

   查看详情 DOI
4. Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.
   T J Martin, N A Sims, K W Ng
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18338097

   The understanding of cell interactions and genetic controls of bone cells has provided new approaches to drug development for osteoporosis. Current emphasis in the development of new anabolic therapie…

   查看详情 DOI
5. Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study.
   G Zhai, D J Hart, A M Valdes, B S Kato, J B Richards, A Hakim
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18305885

   In this 15-year follow-up study, we found that the estimated rate of bone loss at the femoral neck (FN) for women aged 45-68 was linear at a rate of 1.67% per year, but quadratic for lumbar spine (LS)…

   查看详情 DOI
6. Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents.
   K W Lyles, A P Schenck, C S Colón-Emeric
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18301857

   Nursing home residents with a history of hip fractures or prior osteoporotic fractures were found to have an increased risk of another osteoporotic fracture over the ensuing two years when compared to…

   查看详情 DOI
7. Effect of calcium supplementation on hip fractures. 补钙对髋部骨折的影响
   I R Reid, M J Bolland, A Grey
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18286218

   There have been numerous studies of the effects of calcium supplementation, with or without vitamin D, on fractures. Individually, they have not provided clarity regarding calcium's anti-fracture effi…

   查看详情 DOI
8. Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.
   S Adami, G Isaia, G Luisetto, S Minisola, L Sinigaglia, S Silvestri
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18286217

   None of the available osteoporosis therapies completely abolish the risk of fracture. Among 862 patients on treatment with antiresorptive agents (alendronate, risedronate, and raloxifene) for >1 year …

   查看详情 DOI
9. Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.
   P D Delmas, S R Davis, J Hensen, S Adami, S van Os, E A Nijland
   Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18256777

   A randomized trial was conducted in osteopenic postmenopausal women to compare the efficacy of tibolone versus raloxifene on BMD of the lumbar spine and hip. Tibolone increased lumbar spine and total …

   查看详情 DOI
10. Short-term effect of ovariectomy on osteoprogenitors in the healing rat mandibular incisor extraction socket.
    K Shoji, N Basso, E S Elsubeihi, J N M Heersche
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008 IF: 5.40 Q1 PMID: 18250948

    OVX increased the percentage of AP-positive CFU-F in healing rat mandible. The increase of the number of osteoprogenitors was not significant in rat mandible-derived cultures but was in femur-derived …

    查看详情 DOI